miR-143通过抑制PTN促进人骨髓间充质干细胞成脂分化

目的：研究miR-143调控人骨髓问充质干细胞（hMSCs）成脂分化的新机理。方法：将NC、miR-143、siPTN、miR-143i转入hMSCs中,诱导成脂分化,检测miR-143对成脂分化的影响。经miRNA靶点分析软件Findtar预测出miR-143在人多效生长因子（hPTN）的3＇-UTR端有靶点。RT-PCR、westernblot研究mjR-143与hPTN的关系。构建hPTN3＇-UTR靶位点荧光检测质粒prltk-PTN及其突变质粒prltk-m,验证miR-143是否在人PTN3＇-UTR上有靶点。结果：miR-143促进hMSCs成脂分化,抑制hPTN的mRNA和蛋白表达水平。荧光报告实验证实miR-143在人PTN的3＇-UTR上有靶点。结论：miR-143通过与hPTN3I-UTR上的靶点相结合而抑制hPTN的表达,从而促进了hMSCs成脂分化进程。     

脐带间充质干细胞成脂分化的研究

目的:探讨脐带间充质干细胞向成脂细胞方向分化的潜能,为脂肪组织工程提供一种来源丰富的干细胞来源。方法:采用胰酶和胶原酶Ⅰ型联合消化法获得脐带间充质干细胞,通过免疫细胞化学法对其表面标志物进行鉴定,化学诱导方法诱导脐带间充质干细胞向成脂细胞方向分化,倒置显微镜观察其形态变化,油红O染色对诱导后的细胞进行染色。结果:胰酶和胶原酶Ⅰ联合消化法分离的细胞贴壁生长,呈现成纤维细胞形态,免疫细胞化学显示脐带间充质干细胞表达CD29、CD44和CD105,但不表达CD31、CD34和CD105,脐带间充质干细胞在成脂诱导培养基中细胞生长速度明显减慢,细胞形态转变为肥大、扁平、含有大量脂滴的脂肪细胞,油红O染色示胞浆充满了油滴空泡。结论:脐带间充质干细胞具有向成脂细胞方向分化的潜能,为脂肪组织工程提供了一种来源丰富、免疫力低和低分化的种子细胞。     

原子力显微镜对人羊膜间充质干细胞成脂分化的观察

观察人羊膜间充质干细胞(human amniotic mesenchymal stem cells,hAMSCs)成脂分化前后超微结构及其机械性能的变化,以期进一步了解hAMSCs在体外成脂分化的过程。用流式细胞仪分析细胞表面分子表达情况,油红O染色检测hAMSCs成脂分化情况,原子力显微镜观察(AFM)分化前后超微结构及机械性能的变化等。结果显示,流式细胞检测显示,CD34,CD45,HLA-DR,呈阴性表达,CD29,CD90呈阳性表达;油红O染色可见脂肪细胞胞质中有大小不等的圆性红色脂肪滴;AFM观察诱导后的hAMSCs表面有脂滴状的颗粒,粘弹力增大,硬度减小。运用AFM可以清晰观察到诱导前后形貌及机械性能变化。     

重组人干扰素β1a对人骨髓间充质干细胞成软骨细胞定向分化的影响

重组人干扰素β(rhIFN-β)是通过基因表达的一种糖蛋白,具有抗病毒、抗肿瘤和免疫调节作用,虽有研究表明其他亚型干扰素如干扰素γ对细胞增殖和分化有一定的作用,但rh IFN-β对人骨髓间充质干细胞(hMSCs)诱导分化的影响尤其是成软骨细胞定向分化的研究尚少。文中采用成球法研究在常规TGF-β3诱导分化培养基中添加重组IFN-β1a后对诱导hMSCs分化成软骨球的影响。hMSCs经诱导分化后,收集软骨球,通过定量检测糖胺多糖(GAG)含量、软骨球形态测定、Alcian Blue组织染色、Real-time PCR和Western blotting检测Sox9和CollangenⅡ的表达。结果显示,在常规TGF-β3诱导分化培养基中添加100 ng/mL IFN-β1a能显著提高GAG含量,增大软骨球尺寸,促进聚集蛋白聚糖形成,上调Sox9和CollangenⅡ的表达。研究结果表明,重组人IFN-β1a能够与TGF-β3联合作用促进h MSCs成软骨细胞定向分化。     

大戟苷抑制大鼠骨髓间充质干细胞成骨分化

目的:观察泽漆主要活性成分大戟苷(euphornin)对大鼠骨髓间充质干细胞(rMSC)成骨分化的影响。方法:从大鼠股骨中分离培养rMSC,并诱导其成骨分化。用MTT法检测细胞增殖情况,通过茜素红染色,碱性磷酸酶(ALP)活性检测和钙含量测定分别定性、定量地判断其在成骨分化中的效果。实时定量PCR(Q-PCR)检测主要成骨标志因子骨桥蛋白(OPN)和一型胶原蛋白(COL-Ⅰ)及主要转录因子骨形成蛋白2(BMP2)、Runt相关转录因子2(Runx2)和Osterix(Osx)mRNA的表达。结果:大戟苷能剂量依赖性地抑制rMSC成骨分化,并一定程度地抑制其细胞增殖。COL-Ⅰ和OPN的表达在第4、8天分别有显著下降。BMP2、Runx2和Osx等关键转录因子的表达也被明显抑制。结论:大戟苷能抑制rMSC成骨分化,其作用主要是通过抑制BMP通路相关因子的表达而实现的。     

全反式维甲酸抑制猪脂肪间充质干细胞的成脂分化

分离培养猪脂肪间充质干细胞（adipose mesenchymal stem cells, AMSCs）,流式细胞仪鉴定其表面标记.利用MTT比色检测不同浓度的全反式维甲酸（all trans retinoic acid, ATRA）对猪AMSCs增殖的影响;光学显微镜下观察猪AMSCs向脂肪细胞分化的形态学变化;油红O染色提取法分析不同浓度ATRA对猪AMSCs成脂分化的影响;RT PCR检测脂肪细胞分化标志基因LPL和aP2 mRNA的变化.MTT比色结果显示,生理浓度（1×10^－9～1×10^－8 mol/L）和药理浓度（1×10^－7～1×10^－5 mol/L）ATRA对猪AMSCs增殖均没有影响.油红O染色提取法结果表明,除1×10^－7　mol/L ATRA对猪AMSCs成脂分化没有影响外,生理浓度（1×10^－9～1×10^－8 mol/L）和其它药理浓度（1×10^－6～1×10^－5 mol/L）ATRA均显著抑制猪AMSCs成脂分化（P<0.05）.RT-PCR检测显示,ATRA显著抑制脂肪细胞分化标志基因LPL和aP2 mRNA表达（P<0.05）.     

间充质干细胞成骨分化与成脂分化关键基因的生物信息学分析

为探讨间充质干细胞发生成骨分化和成脂分化的潜在关联,本研究首先基于文献挖掘统计间充质干细胞成骨分化和成脂分化相关的差异表达基因,利用DAVID在线软件对差异表达基因进行功能注释和通路富集分析,得到成骨分化GO分类281种,KEGG通路13条(P＜0.01);成脂分化GO分类317种,KEGG通路47条(P＜0.01)....     

Arg缓解MSTN对猪肌肉间充质干细胞成脂-分化的抑制

间充质干细胞可分化为脂肪细胞并沉积脂质,从而增加动物脂肪沉积.因此,猪肌肉间充质干细胞被认为是肌内脂肪的重要来源之一.本研究主要在体外探讨了肌肉生长抑制素（MSTN）对猪肌肉来源间充质干细胞成脂分化的影响及Arg的调控作用.结果表明,外源添加MSTN活性蛋白极显著地降低了胞内甘油三酯水平,而添加Arg或MSTN抗体则表现相反的作用（P〈0.01）.同时添加Arg可缓解MSTN对间充质干细胞脂质沉积的抑制作用（P〈0.01）.生脂转录因子表达模式分析表明,外源添加MSTN抑制了细胞PPARγ2和aP2的表达,添加Arg和MSTN抗体增强了细胞ADD1的表达（P〈0.01）.此外,同时添加MSTN蛋白和Arg较仅添加MSTN蛋白极显著增强了细胞ADD1和PPARδ的表达（P〈0.01）,同时添加MSTN和Arg抗体较仅添加MSTN抗体显著增强了细胞ADD1,PPARδ,C/EBPα,PPARγ2和LPL的表达（P〈0.05）.由此可见,MSTN抑制了猪肌肉来源间充质干细胞成脂分化,添加Arg至少部分地通过上调ADD1和PPARδ的表达来缓解MSTN对成脂分化的抑制作用.     

精氨酸甲基转移酶（PRMT）7通过IGF-1信号通路调控人骨髓间充质干细胞成脂分化的研究

目的 本研究旨在明确精氨酸甲基转移酶（PRMT）7在人骨髓间充质干细胞（hBMSCs）成脂分化过程中的变化以及是否调控hBMSCs成脂分化,进而探索相应的调控机制。方法 通过定量反转录PCR（qRT-PCR）和蛋白质印迹（Western blot）检测hBMSCs成脂分化过程中PRMT7的变化;通过qRT-PCR和Western blot实验证明PRMT7稳定敲低细胞系构建成功。进行油红O染色和定量分析,以及qRT-PCR和Western blot实验检测PRMT7稳定敲低细胞系成脂分化水平的变化;通过裸鼠体内异位成脂实验,油红O染色检测PRMT7稳定敲低细胞系体内异位成脂的效果;通过qRT-PCR和Western blot证明PRMT7稳定过表达细胞系构建成功。进行油红O染色和定量分析以及qRT-PCR和Western blot实验检测PRMT7稳定过表达细胞系成脂分化水平的变化;通过qRT-PCR和Western blot实验检测敲低PRMT7和过表达PRMT7的细胞中IGF-1表达水平的变化。在PRMT7稳定敲低细胞系中转染siIGF-1并通过qRT-PCR和Western blot检测IGF-1的表达水平验证敲低效率。通过油红O染色和定量分析,qRT-PCR实验检测转染siIGF-1的敲低组hBMSCs成脂分化水平的变化。结果 本文发现：在hBMSCs成脂过程中,PRMT7表达水平明显降低（P<0.01）;敲低PRMT7后hBMSCs的成脂分化能力增强（P<0.001）;敲低PRMT7后hBMSCs的体内异位成脂分化能力增强;过表达PRMT7后hBMSCs的成脂分化能力减弱（P<0.01）;PRMT7敲低后IGF-1表达水平增加（P<0.000 1）;PRMT7过表达后IGF-1表达水平降低（P<0.000 1）;转染siIGF-1后,各细胞系IGF-1表达水平明显降低（P<0.001）;敲低组转染siIGF-1后成脂分化能力明显降低（P<0.01）。结论 本研究通过细胞水平和裸鼠皮下移植实验发现PRMT7显著抑制hBMSCs成脂分化,机制研究发现PRMT7对hBMSCs成脂分化的调控作用依赖IGF-1信号通路。上述研究表明,PRMT7可能是治疗相关疾病的潜在分子靶点,为PRMT7和hBMSCs应用于相关疾病治疗提供了新思路。     

抑制Hedgehog信号通路促进C3H10T1/2间充质干细胞成脂分化

激活Hedgehog信号通路可抑制间充质干细胞成脂分化,但抑制Hedgehog信号通路是否可促进脂肪细胞分化研究结果却并不一致.本研究采用环靶明诱导C3H10T1/2细胞成脂分化,并以国际公认的成脂诱导剂混合物（胰岛素、地塞米松、吲哚美辛和IBMX）诱导细胞分化作为参考. qRT-PCR结果显示,在10 μmol/L环靶明(cyclopamine)处理的C3H10T1/2细胞中,Hedgehog信号通路各基因相对表达量显著下降,而成脂分化调控基因PPARγ,C/EBPα和成脂分化标志基因FABP4相对表达量显著升高（P < 0.05). 与此一致,Western印迹结果表明,在环靶明处理的C3H10T1/2细胞中,Hedgehog信号通路中的Shh蛋白和Gli1蛋白表达水平显著下降,成脂分化相关的PPARγ、C/EBPα和FABP4蛋白表达水平显著升高（P < 0.05）. 此外,油红O染色方法证明,环靶明处理可诱导C3H10T1/2细胞成脂分化.以上研究结果提示,抑制Hedgehog信号通路对小鼠胚胎间充质干细胞的成脂分化具有促进作用,并可能为瘦肉型猪的培育和猪肉品质调控研究提供参考依据.     

The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer

BackgroundProstate cancer (PCa) is the most common type of solid tissue cancer among men in western countries. In this study, we determined the levels of circulating miR-21, miR-142, miR-143, miR-146a, and RNU 44 levels as controls for early diagnosis of PCa.MethodsThe circulating miRNA levels in peripheral blood samples from 43 localized PCa patients, 12 metastatic PCa (MET) patients, and a control group of, 42 benign prostate hyperplasia (BPH) patients with a total of 97 volunteers were determined the by PCR method.ResultsNo differences in the DCT values were found among the groups. In PCa and PCaMet groups the expression of miR21 and miR142 were higher compared to the BHP group. No other differences were observed among the other groups. miR21 expression in the PCa group was 6.29 folds upregulated whereas in the PCaMet group 10.84 folds up-regulated. When the total expression of miR142 is evaluated, it showed a positive correlation with mir21 and mir 146 (both p<0.001). Also, the expression of miR146 shows a positive correlation with both miR21 and miR143 (both p<0.001). Expression of miRNAs was found to be an independent diagnostic factor in patients with Gleason score, PSA, and free PSA levels.ConclusionsOur study showed that co-expression of miR21, miR-142, miR-143, and miR-146a and the upregulation of miR-21 resulted in increased prostate carcinoma cell growth. In the PCaMet group, miR21 is the most upregulated of all miRNAs. These markers may provide a novel diagnostic tool to help diagnose PCa with aggressive behavior.     

miR-143在人膀胱癌细胞中的作用及机制

目的：microRNAs（miRNAs）的异常表达与多种疾病密切相关,并有可能用于肿瘤治疗。本研究探讨了miR一143在人膀胱癌细胞中的作用及机制,为膀胱癌的临床诊治提供参考。方法：采用体外培养的T24细胞株为研究对象,按照处理方式分为空白对照组（T24）、阴性对照组（NC）、miRNA-143转染组（miR-143）以及si—COX-2转染组（si—COX-2）。3H—thymidine法和Transwell趋化实验检测T24细胞增殖和迁移能力,免疫印迹法检测COX一2蛋白表达变化。结果：miR-143和si—COX-2转染T24细胞48h-72h后,细胞增值能力较正常T24细胞相比下降36％．49％（P〈0．01）,迁移能力下降81％。免疫印迹结果表明,si—COX-2或miR-143转染的T24细胞内源性COX-．2表达水平显著减少至正常T24细胞表达水平的O．39和0-31倍（P〈0．01）。结论：miR-143可降低膀胱癌T24细胞增值力和侵袭力,并抑制COX．2表达。miR-143可能通过COX-2通路发挥对膀胱癌T24细胞的增殖和侵袭的抑制作用。研究结果更加明确了microRNA在癌症中的功能,提示miR-143可作为膀胱癌的治疗候选药物。本研究为探索肿瘤生物标志物和治疗提供新的启示。     

hMSCs成骨诱导前后免疫调节的实验研究

目的:从免疫学机制方面探讨人骨髓间充质干细胞(Human bone marrow derived mesenchymal stem cell,hMSCs)、成骨诱导后骨髓间充质干细胞(Osteogenic cells differentiated from mesenchymal stem cells,DOC)免疫调节作用的可能机理。方法:hMSCs、DOC(成骨诱导6天、12天、18天),采用流式细胞技术(FACS),分别检测CD40、CD154、CD80、CD86、HLH-Ⅰ、HLA-Ⅱ在诱导前后其表达水平的变化。hMSCs和DOC(诱导18天),分别作混合淋巴细胞反应(CCK-8法),检测不同数量级hMSCs、DOC体外对双向混合淋巴细胞反应体系同种异体PBMCs增殖的影响,以及不同数量级hMSCs、DOC对经植物血凝素(PHA)刺激后同种异体PBMCS增殖的的影响。结果:hMSCs、DOC低水平表达CD40、CD154、CD80、CD86和HLA-Ⅱ,高水平表达HLA-Ⅰ。不同数量级hMSCs、DOC均可不同程度抑制同种异体PBMCs的增殖反应,其抑制效果大体与细胞量成正比,与阳性对照组相比,均有统计学差异(P<0.01)。结论:在体外实验中,hMSCs、DOC可能通过低免疫原性和降低T细胞的免疫应答从而维持其免疫调节功能。     

MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene

High glycolysis, well known as "Warburg effect," is frequently observed in a variety of cancers. Whether the deregulation of miRNAs contributes to the Warburg effect remains largely unknown. Because miRNA regulates gene expression at both mRNA and protein levels, we constructed a gene functional association network, which allows us to detect the gene activity instead of gene expression, to integratively analyze the microarray data for gene expression and miRNA expression profiling and identify glycolysis-related gene-miRNA pairs deregulated in cancer. Hexokinase 2 (HK2), coding for the first rate-limiting enzyme of glycolysis, is among the top list of genes predicted and potentially regulated by multiple miRNAs including miR-143. Interestingly, miR-143 expression was inversely associated with HK2 protein level but not mRNA level in human lung cancer samples. miR-143, down-regulated by mammalian target of rapamycin activation, reduces glucose metabolism and inhibits cancer cell proliferation and tumor formation through targeting HK2. Collectively, we have not only established a novel methodology for gene-miRNA pair prediction but also identified miR-143 as an essential regulator of cancer glycolysis via targeting HK2.     

Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling

Recent evidence has indicated that miRNAs play important roles in carcinogenesis. The identification of dysregulated miRNAs and the target genes they regulate might enhance our understanding of the molecular mechanisms of nasopharyngeal carcinoma (NPC). A microarray analysis was performed to identify dysregulated miRNAs in NPC tissue samples, and protein-coding genes targeted by three or more downregulated miRNAs were selected using miRWalk and used in a pathway enrichment analysis. Nineteen KEGG pathways were selected by DAVID, including the MAPK, focal adhesion, gap junction, ECM–receptor interaction, TGF-beta, and p53 signalling pathways, most of which are involved in NPC carcinogenesis and progression. MiR-143 was significantly downregulated in NPC cell lines and clinical samples. The ectopic expression of miR-143 suppressed NPC cell viability, colony formation, and anchorage-independent growth in vitro, and it inhibited xenograft tumour growth in vivo. Furthermore, KRAS was confirmed as a direct target of miR-143, and silencing KRAS expression suppressed NPC cell viability and proliferation. The miR-143/KRAS pathway provides new insight into the molecular mechanisms that regulate the development and progression of NPC, and it provides novel therapeutic targets for NPC.     

Effect of miR-143-3p on C2C12 myoblast differentiation

MicroRNAs are a class of 18–22 nucleotide non-coding RNAs that modulate gene expression by associating with the 3′ untranslated regions of mRNAs. A large number of microRNAs are involved in the regulation of myoblast differentiation, many of which remain undiscovered. In this study, we found that miR-143-3p was upregulated during C2C12 myoblast differentiation and over-expression of miR-143-3p significantly inhibited the relative expression levels of MyoD, MyoG, myf5, and MyHC genes, especially in the later stages of differentiation. In addition, miR-143-3p inhibited expression of genes involved in the endogenous Wnt signaling pathway during C2C12 myoblast differentiation, including Wnt5a, LRP5, Axin2, and β-catenin. These results indicate that miR-143-3p represents a new myogenic differentiation-associated microRNA that can inhibit C2C12 myoblast differentiation, especially in the later stages of differentiation.     

LncRNA TUG1 regulates FGF1 to enhance endothelial differentiation of adipose-derived stem cells by sponging miR-143

Adipose-derived stem cells (ADSCs) have emerged as a cell source for regeneration medicine. ADSCs possess the capacity to differentiate into endothelial cells and serve an essential role in vascular development and function. LncRNA taurine upregulated gene 1 (TUG1) has recently been linked with angiogenesis in hepatoblastoma. However, the roles of TUG1 in endothelial differentiation of ADSCs remain unidentified. Human adipose-derived stem cells (hADSCs) were obtained and characterized by flow cytometry, Oil red O and Alizarin Red staining. HADSCs were maintained in the endothelial differentiation medium and the expressions of TUG1, miR-143, and FGF1 were examined by qRT-PCR. To assess endothelial differentiation, the expressions of CD31, von Willebrand factor (vWF), VE-cadherin were examined by Western blot analysis, qRT-PCR, and immunofluorescence. Tube formation in Matrigel was examined. The interactions between TUG1 and miR-143, miR-143 and FGF1 were validated by luciferase assays. During the endothelial differentiation process, TUG1 and FGF1 were upregulated, whereas miR-143 was downregulated. TUG1 overexpression downregulated miR-143, upregulated FGF1, CD31, vWF, and VE-cadherin, and enhanced capillary tube formation. Luciferase assays showed that TUG1 interacted with miR-143, and FGF1 was a direct target of miR-143. Furthermore, the enhancement of endothelial differentiation induced by TUG1 overexpression was abolished by miR-143 overexpression. Our findings implicated that lncRNA TUG1 promoted endothelial differentiation of ADSCs by regulating the miR-143/FGF1 axis.     

miR-143-3p促进C2C12成肌细胞分化

MicroRNAs (miRNAs) 是一类小非编码RNA,近年研究发现其在骨骼肌发育调控中发挥重要作用.为探明miR-143-3p在C2C12成肌细胞分化中的调控作用,采用 real-time PCR 检测了miR-143-3p在小鼠各组织及C2C12成肌细胞分化过程中的表达;使用miR-143-3p 的模拟物和特异性抑制剂分别处理细胞,采用 real-time PCR 和 Western印迹分别检测成肌因子 MyoG和成肌标志基因 MyHC mRNA和蛋白水平的变化;用免疫荧光染色的方法观察肌管的形成.结果显示,miR-143-3p在小鼠各组织中均有表达,并且随着细胞分化表达量逐渐增加;C2C12成肌细胞过表达 miR-143-3p,与对照组相比,成肌调控因子MyoG和成肌标志基因MyHC 的mRNA和蛋白表达均显著升高,肌管数量明显增多;抑制剂处理结果显示,细胞分化被显著抑制.检测miR-143-3p对MyHC各亚型表达的影响发现,miR-143-3p表达的变化并不直接影响MyHC各亚型的表达.以上结果说明, miR-143-3p在骨骼肌和成肌细胞中均有表达,能够促进C2C12成肌细胞分化,但并不直接调控MyHCs的表达.